Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Lysates
  5. Overexpression Lysates
  6. NBL114484

Novus Biologicals™ t-Plasminogen Activator/tPA Overexpression Lysate
SDP

Catalog No. NBL114484 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBL114484 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBL114484 Supplier Novus Biologicals™ Supplier No. NBL114484
Only null left
Add to Cart
Add to Cart

Description

The t-Plasminogen Activator/tPA Overexpression Lysate is derived from human. It has been validated for the following applications: Western Blot.

Specifications

Cell Line The lysate was created in HEK293T cells, using plasmid ID RC21571 and based on accession number NM_93. The protein contains a C-terminal DDK tag.
For Use With (Application) Western Blot
Quantity 0.1 mg
Storage Buffer RIPA buffer
Purity Protein
Test Specificity Homo sapiens plasminogen activator, tissue (PLAT), transcript variant 1, mRNA.
Content And Storage -80°C. Avoid freeze-thaw cycles.
Synonym alteplase, DKFZp686I03148, EC 3.4.21, EC 3.4.21.68, plasminogen activator, tissue, plasminogen activator, tissue type, reteplase, tissue plasminogen activator (t-PA), tissue-type plasminogen activator, t-PA, TPA, t-plasminogen activator
Protein State Native

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.